World leaders, civil society and global health researchers will convene at the United Nations General Assembly for arguably the most important meeting on antimicrobial resistance (AMR) this decade.
There are many ways to kill microbes that cause dangerous infections. Combining genetic screening with machine learning can help researchers identify new antimicrobials.
The contrasting realities of antimicrobial resistance between high-income countries and low- and middle-income countries demands international co-operation to effectively fight superbugs.
Developing new antibiotics is important in the fight against antibiotic resistance. But we also need to use the antibiotics we already have much more wisely – GPs play a major role in this.
Africa bears the heaviest burden of antimicrobial resistance, a phenomenon fuelled largely by poverty, But there are encouraging signs that the continent is taking action to fight it.
Antimicrobial resistance is an epidemic that kills close to 5 million people annually. The solutions are complex and must take into account the needs of the poor.
Sacha Pidot, The Peter Doherty Institute for Infection and Immunity
Scientists are racing to discover new antibiotics that can defeat these drug-resistant superbugs. So how is the newly developed antibiotic clovibactin different?
Up to 20% of Australians admitted in hospital say they have a penicillin allergy. But not everyone who thinks they’re allergic to penicillin actually is.
Consultant Microbiologist, Beaumont Hospital, Dublin, Ireland and Professor and Head of Department, Clinical Microbiology, RCSI University of Medicine and Health Sciences